Human Papillomavirus (HPV) vaccination among young adults

October 2025
Vol-11, Issue-5
Paper ID: 27543
ISSN: 2395-4396
Downloads: 117
Download PDF

Abstract & Details

Research Area
Medical
Keywords
Human papillomavirus (HPV) cervical cancer (CC) sexually transmitted infection (STI) Prevention and Cervical intraepithelial neoplasia (CIN).
Abstract
We currently have the knowledge and experience to prevent much of human papillomavirus (HPV)-related disease burden globally. We are already observing, in real-world settings, a decrease in vaccine-related HPV-type infections, genital warts, and cervical pre-cancers, with possible decreases in vulvar, vaginal, and anal pre-cancers, in many countries where prophylactic HPV vaccination programs have been adopted as highly effective public health programs with good vaccine coverage. Furthermore, compared to traditional cervical cytology, HPV-based screening programs now have solid evidence to support their usage as more sensitive methods of detecting underlying cervical abnormalities, which is causing a shift in the paradigms surrounding cervical screening. This article explains how preventive vaccination affects these results and the environments in which national immunization programs have used these vaccinations. There has been a global effort to guarantee that every woman has access to efficient cervical screening and every girl has the chance for primary prevention through immunization, given the achievements made so far and the accessibility of necessary resources. Given that guys are also susceptible to HPV-related malignancies, some nations have also chosen to take a gender-neutral stance by vaccinating young boys. Additionally, immunizing young boys has the benefit of lowering the infectious pool of HPV in the general population, lowering the chance of HPV transmission to sexual partners, and ultimately lowering the risk of HPV-related diseases for both sexes. Thus, it makes sense for all nations to take into account and support national policies and initiatives aimed at preventing diseases linked to HPV.

Author Information

# Name Institute / Affiliation
1 Dr. Isma Bibi Clinical Gynaecology and Obstetrics, Tumor Hospital of Xinjiang Medical University
2 Professor Guqun Shen Clinical Gynaecology and Obstetrics, Tumor Hospital of Xinjiang Medical University

How to Cite

Use the following formats to cite this article in your research.

APA Style
Bibi, Dr. Isma & Shen, Professor Guqun (2025). Human Papillomavirus (HPV) vaccination among young adults. International Journal of Advance Research and Innovative Ideas In Education, 11(5), 546-557.
MLA Style
Bibi, Dr. Isma, and Professor Guqun Shen. "Human Papillomavirus (HPV) vaccination among young adults." International Journal of Advance Research and Innovative Ideas In Education, vol. 11, no. 5, 2025, pp. 546-557.
IEEE Style
Dr. Isma Bibi and Professor Guqun Shen, "Human Papillomavirus (HPV) vaccination among young adults," International Journal of Advance Research and Innovative Ideas In Education, vol. 11, no. 5, pp. 546-557, 2025.
Vancouver Style
Bibi Dr. Isma, Shen Professor Guqun. Human Papillomavirus (HPV) vaccination among young adults. International Journal of Advance Research and Innovative Ideas In Education. 2025;11(5):546-557.
Harvard Style
Bibi, Dr. Isma & Shen, Professor Guqun (2025) 'Human Papillomavirus (HPV) vaccination among young adults', International Journal of Advance Research and Innovative Ideas In Education, 11(5), pp. 546-557.
Chicago Style
Bibi, Dr. Isma and Professor Guqun Shen. "Human Papillomavirus (HPV) vaccination among young adults." International Journal of Advance Research and Innovative Ideas In Education 11, no. 5 (2025): 546-557.
Turabian Style
Bibi, Dr. Isma and Professor Guqun Shen. "Human Papillomavirus (HPV) vaccination among young adults." International Journal of Advance Research and Innovative Ideas In Education 11, no. 5 (2025): 546-557.

Export Citation